Intrinsic Value of S&P & Nasdaq Contact Us

Nutriband Inc. NTRB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Nutriband Inc. (NTRB) has a negative trailing P/E of -3.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 2.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -26.49%, forward earnings yield 38.61%. PEG 0.02 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.02).
  • Forward P/E 2.6 — analysts expect a return to profitability with estimated EPS of $1.57 for FY2027.
  • PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -26.49% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 38.61% as earnings recover.

Overall SharesGrow Score: 50/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
27/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — NTRB

Valuation Multiples
P/E (TTM)-3.8
Forward P/E2.6
PEG Ratio0.02
Forward PEG0.02
P/B Ratio6.39
P/S Ratio21.38
EV/EBITDA-3.5
Per Share Data
EPS (TTM)$-1.06
Forward EPS (Est.)$1.57
Book Value / Share$0.63
Revenue / Share$0.19
FCF / Share$-0.47
Yields & Fair Value
Earnings Yield-26.49%
Forward Earnings Yield38.61%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -86,919.0 0.00 -3,031.18 0.00 -
2017 -229.9 -0.01 1,504.50 0.00 -
2018 -12.0 -0.01 264.71 0.00 -
2019 -10.8 -1.03 14.91 146.13 -
2020 -13.0 0.77 207.04 98.00 -
2021 -12.0 -1.32 5.43 40.95 -
2022 -3.5 -0.03 2.51 20.92 0.66%
2023 -6.4 0.14 3.60 14.85 -
2024 -3.8 -0.18 3.22 9.96 -
2025 -8.4 -0.19 13.68 41.09 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $0.00 $0.00 $-400.00 -
2016 $-0.03 $0.00 $-151.26K -
2017 $-0.48 $0.00 $-2.67M -
2018 $-0.53 $245.29K $-3.33M -1358.1%
2019 $-0.44 $370.65K $-2.8M -754.1%
2020 $-0.48 $943.7K $-3.21M -340.5%
2021 $-1.06 $1.42M $-8.42M -592.2%
2022 $-0.57 $2.08M $-4.81M -231.3%
2023 $-0.69 $2.09M $-5.49M -263%
2024 $-0.99 $2.14M $-10.48M -489.9%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-6.20 $-6.20 – $-6.20 $2.73M $2.73M – $2.73M 1
2027 $1.57 $1.57 – $1.57 $95.41M $95.41M – $95.41M 1
2028 $3.66 $3.66 – $3.66 $180.41M $180.41M – $180.41M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message